IRIS - Res&Arch Institutional Research Information System - Research & Archive

VELARDI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.505
EU - Europa 4.869
AS - Asia 4.591
SA - Sud America 767
Continente sconosciuto - Info sul continente non disponibili 420
AF - Africa 126
OC - Oceania 7
Totale 17.285
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.343
SG - Singapore 2.106
IT - Italia 829
IE - Irlanda 786
CN - Cina 658
UA - Ucraina 625
RU - Federazione Russa 602
SE - Svezia 595
BR - Brasile 591
HK - Hong Kong 584
VN - Vietnam 483
FI - Finlandia 319
DE - Germania 318
FR - Francia 273
GB - Regno Unito 190
KR - Corea 164
BD - Bangladesh 130
IN - India 108
CA - Canada 74
TR - Turchia 67
AR - Argentina 59
IQ - Iraq 51
PL - Polonia 46
MX - Messico 45
NL - Olanda 45
ZA - Sudafrica 41
CH - Svizzera 40
AT - Austria 36
BE - Belgio 33
UZ - Uzbekistan 30
PK - Pakistan 28
CZ - Repubblica Ceca 26
JP - Giappone 26
CO - Colombia 25
RO - Romania 25
EC - Ecuador 24
ID - Indonesia 23
SA - Arabia Saudita 22
PH - Filippine 21
ES - Italia 20
VE - Venezuela 18
GR - Grecia 17
CL - Cile 14
BO - Bolivia 13
EG - Egitto 13
JO - Giordania 13
MA - Marocco 13
TN - Tunisia 12
CR - Costa Rica 10
KE - Kenya 10
LT - Lituania 10
PE - Perù 10
LB - Libano 9
PY - Paraguay 9
IL - Israele 8
MY - Malesia 8
DZ - Algeria 7
OM - Oman 7
AZ - Azerbaigian 6
ET - Etiopia 6
JM - Giamaica 6
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
NP - Nepal 5
AU - Australia 4
BG - Bulgaria 4
DK - Danimarca 4
EU - Europa 4
GE - Georgia 4
HN - Honduras 4
KZ - Kazakistan 4
NI - Nicaragua 4
PS - Palestinian Territory 4
PT - Portogallo 4
DO - Repubblica Dominicana 3
GT - Guatemala 3
HR - Croazia 3
LV - Lettonia 3
ML - Mali 3
NG - Nigeria 3
QA - Qatar 3
AL - Albania 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CM - Camerun 2
EE - Estonia 2
KG - Kirghizistan 2
MK - Macedonia 2
MU - Mauritius 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
TJ - Tagikistan 2
TW - Taiwan 2
UG - Uganda 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
Totale 16.842
Salva come PNG Salva come JPEG
Città #
Singapore 1.528
Dublin 786
Chandler 741
San Mateo 604
Hong Kong 581
San Jose 566
Ashburn 429
Jacksonville 325
Boardman 318
Perugia 290
Santa Clara 256
Moscow 204
Dong Ket 178
Medford 176
Princeton 175
Beijing 173
Altamura 168
Lauterbourg 163
Seoul 159
Ann Arbor 147
Wilmington 138
Lawrence 127
Andover 120
Los Angeles 115
New York 111
Ho Chi Minh City 105
Munich 98
Helsinki 94
Piscataway 72
The Dalles 70
Hanoi 64
Turku 64
São Paulo 55
Des Moines 49
Saint Petersburg 49
Norwalk 48
Frankfurt am Main 42
Shanghai 38
Orem 35
Woodbridge 33
Houston 30
Dallas 29
London 29
Brooklyn 28
Johannesburg 28
Rome 28
Brussels 27
Izmir 27
Milan 27
Warsaw 27
San Paolo di Civitate 26
Montreal 25
Redmond 25
Tokyo 25
Stockholm 24
Amsterdam 23
Atlanta 22
Baghdad 22
Boston 21
Phoenix 20
Rio de Janeiro 20
Bucharest 19
Chennai 19
Denver 19
Falls Church 19
Nuremberg 19
Brno 18
Chicago 18
Hefei 18
San Francisco 18
Dearborn 16
Falkenstein 15
Vienna 15
Belo Horizonte 14
Da Nang 14
Tashkent 14
Toronto 14
Auburn Hills 13
Bologna 13
Espoo 13
Florence 13
Foligno 13
Guangzhou 13
Quito 13
Brasília 12
Columbus 12
Manchester 12
New Delhi 12
Redwood City 12
Curitiba 11
Dhaka 11
Medellín 11
Prata Di Pordenone 11
Council Bluffs 10
Mumbai 10
Philadelphia 10
Riyadh 10
Terni 10
Tianjin 10
Barnet 9
Totale 10.560
Salva come PNG Salva come JPEG
Nome #
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO) 189
Advances in full-haplotype mismatched transplants in acute leukemia 188
Innate immunity against hematological malignancies 163
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 158
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells 149
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 146
14th International HLA and Immunogenetics Workshop: Report on hematopoietic cell transplantation. 140
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. 139
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 131
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 130
A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation 128
Fourth international workshop on haploidentical transplants, Naples, Italy 127
Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk 127
"Designed" grafts for HLA-haploidentical stem cell transplantation. 126
Noncanonical Fungal Autophagy Inhibits Inflammation in Response to IFN-γ via DAPK1. 126
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 125
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 125
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 124
Genetic polymorphisms affecting IDO1 or IDO2 activity differently associate with aspergillosis in humans 124
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 123
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 122
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 122
T helper 2 antagonists restore antifungal T helper immunity in mice with T cell-depleted bone marrow transplantation 122
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 122
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 122
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 121
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 121
TNFR2 signaling modulates immunity after allogeneic hematopoietic cell transplantation 121
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 120
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 120
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 119
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 118
CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation 118
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 116
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 115
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 115
The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism 114
CMV management with specific immunoglobulins: A multicentric retrospective analysis on 92 allotransplanted patients 114
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 113
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 111
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 109
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 109
Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation 108
Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. 107
Allogeneic transplantation across the HLA barriers. 107
New perspectives in haematopoietic stem cell transplantation. Transplantation across HLA barriers. 106
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 106
Increased Ratio of CD31+/CD42- Microparticles to Endothelial Progenitors as a Novel Marker of Atherosclerosis in Hypercholesterolemia. 106
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 105
. Mismatched hematopoietic stem cell transplants in elderly patients. 105
Transplants across human leukocyte antigen barriers 104
16th IHIW: international histocompatibility working group in hematopoietic cell transplantation. 104
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients 103
Allogenic and autologous transplantation for haematological diseases, solid tumours and immune disorders:current practice in europe 2009. 102
Natural killer cell alloreactivity for leukemia therapy. 102
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 102
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors 100
T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease 100
The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation. . 99
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 99
Preclinical characterization of 1-7F9,a novel human anti-KIR receptor therapeutic antibody that augments natural kille-mediated killing of tumor cells. 98
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 98
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 98
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 98
Total Marrow/Total Lymphoid Irradiation as Conditioning for Haploidentical Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients 98
Cellular therapy: exploiting NK cell alloreactivity in transplantation 97
Non-MHC-restricted cytotoxic cells: Their roles in the control and treatment of leukaemias 97
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 97
NCRs and DNAM-1 mediate NK cell recognition and iysis of human and mouse melanoma cell lines in vitro and in vivo 97
The effect of TNF-α on regulatory T cell function in graft-versus-host disease 97
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 97
Natural killer cells: biology and application in stem-cell transplantation 95
Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation 95
Deploying natural killer cell allotherapy in the setting of HLA-haplotype-mismatched hematopoietic stem cell transplantation 95
Haploidentical stem cell transplantation for acute leukemia 94
Natural killer cell-mediated lysis of autologous cells modified by gene therapy 94
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. 94
Striking survival advange of bad-risk acute myeloid leukemia patients transplanted from haploidentical donors with KIR epitope incompatibility in the GVH direction 94
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 94
TLR3 essentially promotes protective class I-restricted memory CD8+ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 94
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 93
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells. 93
Mismatched hematopoietic stem cell transplantation in secondary leukemia 93
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation 93
T cells expressing chimeric antigen receptor promote immune tolerance 93
Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation. 93
Acute GvHD after HLA- Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes 92
Involvement of Cd44 Variant Isoforms In Hyaluronate Adhesion By Human Activated T-cells 92
REGULATORY T CELL ADOPTIVE IMMUNOTHERAPY PROMOTES B CELL IMMUNITY AFTER HAPLOIDENTICAL TRANSPLANTATION 91
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 91
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. 91
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: A retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation 91
Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation. 90
Foxp3+regulatory T cells maintain the bone marrow microenvironment for B cell lymphopoiesis 90
Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation. 89
Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia 89
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants 89
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation 89
New mechanism of lymphoma-induced bone marrow aplasia 89
Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. 88
Totale 10.977
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.669
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.669
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.786 0 486 63 120 77 13 24 491 9 53 230 220
2022/20232.542 193 498 21 188 177 257 5 115 957 10 94 27
2023/20241.124 58 120 43 20 7 19 240 21 120 31 198 247
2024/20252.628 57 270 87 128 362 88 73 187 492 151 488 245
2025/20265.913 407 367 328 733 777 561 976 311 638 520 176 119
2026/2027257 117 140 0 0 0 0 0 0 0 0 0 0
Totale 17.285